Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients
This study has been completed.
Sponsor:
University of Zurich
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT00492895
First received: June 19, 2007
Last updated: August 18, 2011
Last verified: August 2011
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | June 19, 2007 | ||||
| Last Updated Date | August 18, 2011 | ||||
| Start Date ICMJE | June 2007 | ||||
| Primary Completion Date | December 2010 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
Photosensitivity of the skin to UVA and UVB [ Time Frame: 2 years ] [ Designated as safety issue: No ] | ||||
| Original Primary Outcome Measures ICMJE |
Photosensitivity of the skin to UVA and UVB [ Time Frame: 2 years ] | ||||
| Change History | Complete list of historical versions of study NCT00492895 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE | |||||
| Original Secondary Outcome Measures ICMJE | |||||
| Current Other Outcome Measures ICMJE | |||||
| Original Other Outcome Measures ICMJE | |||||
| Descriptive Information | |||||
| Brief Title ICMJE | Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients | ||||
| Official Title ICMJE | Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients | ||||
| Brief Summary | Photosensitivity of the skin to UVA and UVB will be determined |
||||
| Detailed Description | Photosensitivity of the skin to UVA and UVB in renal transplant recipients with and without azathioprine will be determined. Azathioprine will be discontinued and photosensitivity determined after a wash-out period of three months
|
||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Phase 4 | ||||
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Open Label Primary Purpose: Diagnostic |
||||
| Condition ICMJE | Skin Cancer | ||||
| Intervention ICMJE | Drug: Discontinuation of Azathioprin
Discontinuation of Azathioprin
Other Name: Discontinuation of Azathioprin |
||||
| Study Arm (s) | A
one arm only. Crossover study
Intervention: Drug: Discontinuation of Azathioprin |
||||
| Publications * | |||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Enrollment ICMJE | 25 | ||||
| Completion Date | March 2011 | ||||
| Primary Completion Date | December 2010 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion criteria:
Exclusion criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years and older | ||||
| Accepts Healthy Volunteers | Yes | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | Switzerland | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00492895 | ||||
| Other Study ID Numbers ICMJE | 2007DR2040 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Hofbauer Günther, Unversity Hospital Zürich | ||||
| Study Sponsor ICMJE | University of Zurich | ||||
| Collaborators ICMJE | |||||
| Investigators ICMJE |
|
||||
| Information Provided By | University of Zurich | ||||
| Verification Date | August 2011 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||
